The near-infrared spectroscopy (NIRS) patent landscape is rapidly evolving as industries adopt this non-invasive, precise analytical technology for medical, pharmaceutical, and industrial applications. The global NIRS market, valued at USD 635.30 Million in 2025, is projected to grow at a CAGR of 5.70% during 2026–2035, reaching USD 1,105.93 Million by 2035. This growth is closely tied to increasing patent activity focused on advancing device sensitivity, portability, and application versatility.

Near-infrared spectroscopy enables real-time, non-destructive analysis of chemical compositions by measuring the absorption of near-infrared light. Its applications range from tissue oxygenation monitoring and brain functional imaging in healthcare to quality control in pharmaceuticals, food, and chemical industries.

Key Drivers Fueling Patent Growth

Expanding Medical and Clinical Applications: NIRS is increasingly used for cerebral monitoring, tissue oxygenation, and diagnostic imaging.

Technological Innovations: Patents focus on miniaturized devices, improved sensors, wearable systems, and AI-enabled signal processing.

Growing Industrial and Research Applications: Food quality analysis, chemical monitoring, and process control drive innovation and IP filings.

Rising Demand for Non-Invasive Diagnostics: Non-invasive, real-time monitoring reduces patient risk and supports continuous monitoring applications.

Competitive Patent Landscape

The NIRS patent ecosystem is highly competitive, with leading technology and healthcare companies protecting intellectual property:

Artiva Biotherapeutics Inc. & Poseida Therapeutics, Inc. – Patents focus on innovative optical sensing platforms for clinical and research applications.

Nanjing Beiheng Biological Technology Co., Ltd. & NantCell, Inc. – Developing novel devices for real-time monitoring and analytical precision.

Bristol Myers Squibb Company & Compugen LTD – Leveraging expertise in medical instrumentation and analytical technologies to expand IP portfolios.

Others – Emerging startups and research institutions are contributing niche innovations in wearable NIRS devices and AI-powered data analysis.

Download a free sample report along with a complete table of contents for review.

Market Outlook

The near-infrared spectroscopy patent landscape is expected to remain dynamic through 2035, driven by the need for enhanced precision, portability, and diverse application areas. Companies with robust intellectual property portfolios will benefit from licensing, collaborations, and faster commercialization of innovative devices. As NIRS technologies continue to expand in medical diagnostics, research, and industrial quality control, patent activity will remain a key driver of market growth and technological leadership worldwide.